Journal of Clinical Epidemiology | Oct 2026 | To identify the key behavioural determinants that influence how people working in clinical trials (‘trialists’) design and deliver greener trials.
Resource Type Archives
Carbon footprint of clinical research: a systematic review and quantitative synthesis of estimates, sources of variation and emission hotspots
BMJ | Oct 2026 | Nekouei Shahraki M, Van Bodegraven L, De Haes F, et alCarbon footprint of clinical research: a systematic review and quantitative synthesis of estimates, sources of variation and emission hotspots
6 things you can do to reduce the environmental impact of clinical research trials
Imperial | Sept 2026 “Clinical research trials are an essential way to advance medicine and develop treatments that can help people live longer, healthier lives.”
A Perspective on Environmental Sustainability Assessments in the Healthcare Sector
A discussion paper titled “Challenges and recommendations for environmental sustainability assessments of pharmaceutical products in the healthcare sector” has been published in Green Chemistry by Wouter De Soete of Ghent University, Johnson & Johnson, GlaxoSmithKline, the Sustainable Healthcare Coalition and the American Chemical Society. Healthcare represents a significant portion of the global economy so, it Continue reading “A Perspective on Environmental Sustainability Assessments in the Healthcare Sector”
A Manifesto for Global Sustainable Health
A manifesto has been produced that attempts to summarise the thoughts explored by the Sustainable Health Symposium that was held in Cambridge in July, 2017 and sponsored by the Sustainable Healthcare Coalition. Across the globe, the health of individuals, their communities and the planet is in crisis as key drivers including rising inequity, food insecurity, Continue reading “A Manifesto for Global Sustainable Health”
Climate footprint of industry-sponsored in-human clinical trials: life cycle assessments of clinical trials spanning multiple phases and disease areas
BMJ | Feb 2025 | “This study aims to calculate the global warming potential, in carbon dioxide (CO2) equivalent emissions, from all in-scope activities involved in phase 1, 2, 3 and 4 clinical trials spanning multiple disease areas.”
Open Letter to Clinical Trial Community published by members of the Sustainable Markets Initiative Health Systems Task Force
SMI | Feb 2025 “CEOs from AstraZeneca, GSK, Merck, Novo Nordisk, Novartis, Sanofi and Roche have signed the letter”
What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials
BMJ | Oct 2024 “Clinical trials are fundamental to healthcare, however, they also contribute to anthropogenic climate change..”
Quantifying the carbon footprint of clinical trials: guidance development and case studies
BMJ | Jan 2024 “The urgency of the climate crisis requires attention from biomedical research, not least clinical trials which can involve significant greenhouse gas emissions.”
A strategy to reduce the carbon footprint of clinical trials
The Lancet | July 2021 “Clinical trials need to be decarbonised and we propose a strategy for doing so.”
